Myles Minter
Stock Analyst at William Blair
(2.41)
# 2,421
Out of 5,179 analysts
25
Total ratings
52.63%
Success rate
10.55%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Myles Minter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KRRO Korro Bio | Upgrades: Outperform | n/a | $10.40 | - | 3 | Feb 17, 2026 | |
| NMRA Neumora Therapeutics | Upgrades: Outperform | n/a | $2.33 | - | 2 | Feb 17, 2026 | |
| BHVN Biohaven | Downgrades: Market Perform | n/a | $8.37 | - | 1 | Nov 5, 2025 | |
| ALEC Alector | Downgrades: Market Perform | n/a | $2.00 | - | 2 | Oct 22, 2025 | |
| DNTH Dianthus Therapeutics | Initiates: Outperform | n/a | $81.13 | - | 1 | Jul 2, 2025 | |
| IMUX Immunic | Initiates: Outperform | n/a | $1.09 | - | 1 | Mar 25, 2025 | |
| CAMP Camp4 Therapeutics | Initiates: Outperform | n/a | $4.31 | - | 1 | Nov 5, 2024 | |
| ARGX argenx SE | Upgrades: Outperform | n/a | $691.40 | - | 2 | Nov 1, 2024 | |
| ARCT Arcturus Therapeutics Holdings | Initiates: Outperform | $71 | $6.76 | +950.30% | 1 | Jul 24, 2023 | |
| MRNA Moderna | Initiates: Market Perform | n/a | $49.56 | - | 1 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $433.07 | - | 1 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $290.10 | - | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $4.62 | - | 3 | Sep 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $317.36 | - | 1 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $72.15 | - | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $116 | $128.32 | -9.60% | 1 | Feb 24, 2020 |
Korro Bio
Feb 17, 2026
Upgrades: Outperform
Price Target: n/a
Current: $10.40
Upside: -
Neumora Therapeutics
Feb 17, 2026
Upgrades: Outperform
Price Target: n/a
Current: $2.33
Upside: -
Biohaven
Nov 5, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $8.37
Upside: -
Alector
Oct 22, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $2.00
Upside: -
Dianthus Therapeutics
Jul 2, 2025
Initiates: Outperform
Price Target: n/a
Current: $81.13
Upside: -
Immunic
Mar 25, 2025
Initiates: Outperform
Price Target: n/a
Current: $1.09
Upside: -
Camp4 Therapeutics
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $4.31
Upside: -
argenx SE
Nov 1, 2024
Upgrades: Outperform
Price Target: n/a
Current: $691.40
Upside: -
Arcturus Therapeutics Holdings
Jul 24, 2023
Initiates: Outperform
Price Target: $71
Current: $6.76
Upside: +950.30%
Moderna
Jul 24, 2023
Initiates: Market Perform
Price Target: n/a
Current: $49.56
Upside: -
May 30, 2023
Initiates: Outperform
Price Target: n/a
Current: $433.07
Upside: -
Mar 6, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $290.10
Upside: -
Sep 19, 2022
Upgrades: Outperform
Price Target: n/a
Current: $4.62
Upside: -
Jun 7, 2022
Initiates: Outperform
Price Target: n/a
Current: $317.36
Upside: -
Dec 14, 2021
Upgrades: Outperform
Price Target: n/a
Current: $72.15
Upside: -
Feb 24, 2020
Initiates: Outperform
Price Target: $116
Current: $128.32
Upside: -9.60%